Accuray (ARAY) vs PAVmed (PAVM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
PAVmed (PAVM) has outperformed Accuray (ARAY) over the past year, losing 81.2% versus a loss of 83.9%. Over five years, ARAY leads with a -93.6% price change compared with -99.9% for PAVM. Accuray is the larger company by market cap ($28.8 million vs $22.0 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ARAY | PAVM |
|---|---|---|
| Share price | $0.2409 | $2.76 |
| Market cap | $28.77M | $22.03M |
| 1-day change | -4.93% | +0.55% |
| YTD return | -69.10% | -58.67% |
| 1-year return | -83.86% | -81.21% |
| 5-year return | -93.55% | -99.90% |
| EPS (TTM) | $-0.40 | $-14.20 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.10 | $28.44 |
| 52-week low | $0.22 | $2.60 |
| Distance from 52-week high | -88.53% | -90.31% |
| Average volume | 7.19M | 30.46K |
| Shares outstanding | 119.44M | 8.00M |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ARAY vs PAVM FAQ
Which is bigger, Accuray or PAVmed?
Accuray (ARAY) is larger, with a market capitalization of $28.77M compared with $22.03M for PAVmed (PAVM).
Which stock has performed better over the past year, ARAY or PAVM?
PAVM returned -81.21% over the past 12 months, compared with -83.86% for ARAY (price return, excluding dividends). Past performance does not predict future results.
Are Accuray and PAVmed in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.